SPHERA FUNDS MANAGEMENT LTD.

Position in MDWD — MediWound Ltd.

CIK 1496201 TEL AVIV, L3

Position in MDWD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,015,922

-$385,201 QoQ

Shares Held

273,192

0.0% QoQ

Ownership

2.12%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

of 79 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SPHERA FUNDS MANAGEMENT LTD. holds $446,002,188 across 71 Biotechnology names. MDWD ranks #42 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MLYS	Mineralys Therapeutics, Inc.	1,469,971	$39,659,817
2	SNDX	Syndax Pharmaceuticals Inc	1,014,606	$22,179,287
3	RARE	Ultragenyx Pharmaceutical Inc.	588,494	$19,649,814
4	BMRN	Biomarin Pharmaceutical Inc	328,550	$18,799,631
5	CYTK	Cytokinetics Inc	219,987	$18,740,692
6	BBIO	BridgeBio Pharma, Inc.	245,346	$18,273,370
7	COGT	Cogent Biosciences, Inc.	459,340	$17,776,458
8	INSM	INSMED Inc	118,800	$12,666,456

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,015,922	273,192	0.0%	Shares	Defined	2026-08-14
2026-03-31	$4,401,123	273,192	+18.6%	Shares	Defined	2026-05-15
2025-12-31	$4,252,205	230,347	+24.3%	Shares	Defined	2026-02-17
2025-09-30	$3,338,565	185,270	+278.3%	Shares	Defined	2025-11-14
2023-12-31	$498,126	48,980	-54.9%	Shares	Defined	2024-02-15
2023-09-30	$1,154,790	108,533	-2.3%	Shares	Defined	2023-11-14
2023-06-30	$1,184,613	111,127	0.0%	Shares	Defined	2023-08-14
2023-03-31	$1,480,211	111,127	+47.4%	Shares	Defined	2023-05-15
2022-12-31	$1,017,321	75,413	-89.1%	Shares	Defined	2023-02-14
2022-09-30	$957,314	688,716	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.